← Back to the Established firms tiles
Pharmaceuticals
8 records Theme: Pharma and health · Generated from this page's data. Click a name to open its panel on the Established firms page. Records resting on one source are tagged "one source".| Record | What it is | Place | Links | Confidence |
|---|---|---|---|---|
| AstraZeneca and CSPC AI drug discovery collaborationPartnerships and contracts | AstraZeneca pays China's CSPC to find oral drug candidates using CSPC's AI-driven drug discovery platform. | Cambridge (CB2 0AA) | Companies House · astrazeneca.com/media-centre/press-releases/2025 | one source |
| AstraZeneca and insitro AI collaborationPartnerships and contracts | AstraZeneca licenses the US company insitro's AI platform to find drug targets for liver disease and heart muscle disease. | Cambridge (CB2 0AA) | Companies House · astrazeneca.com/media-centre/press-releases/2026 | one source |
| AstraZeneca and Oracle global AI collaborationPartnerships and contracts · also on Big tech in the UK | AstraZeneca and Oracle plan to use Oracle's health data, cloud and AI to speed up clinical trial recruitment and earlier diagnosis. announced | Cambridge (CB2 0AA) | Companies House · astrazeneca.com/media-centre/press-releases/2026 | one source |
| AstraZeneca Enterprise AI unitCompanies | AstraZeneca's in-house AI centre of excellence, which applies AI and data across research, clinical trials, commercial and operations. | Cambridge (CB2 0AA) | Companies House · careers.astrazeneca.com/enterpriseai · astrazeneca.com/media-centre/press-releases/2026 · find-and-update.company-information.service.gov. | verified |
| AstraZeneca iLab (automated AI chemistry lab)Networks, bodies, events and media | AstraZeneca's automated chemistry lab in which AI analyses test results and proposes the next compounds to make. | Gothenburg, Sweden; Cambridge, UK | Companies House · astrazeneca.com/r-d/our-technologies/ilab.html · find-and-update.company-information.service.gov. | one source |
| GSK and Fleming Initiative AI for antimicrobial resistancePartnerships and contracts | GSK and Fleming Initiative scientists build AI models to design new antibiotics and antifungals and predict how drug-resistant infections spread. | London (WC1A 1DG) | Companies House · gsk.com/en-gb/media/press-releases/gsk-and-flemi · find-and-update.company-information.service.gov. | one source |
| GSK and Tempus AI collaborationPartnerships and contracts | GSK pays the US company Tempus for access to its AI-enabled platform and de-identified patient data to design and run drug trials. | London (WC1A 1DG) | Companies House · gsk.com/en-gb/media/press-releases/gsk-announces | one source |
| Oxford-GSK Institute of Molecular and Computational MedicinePartnerships and contracts | A GSK-funded Oxford institute that uses machine learning and genetics to find how diseases such as Alzheimer's and Parkinson's work. | Oxford | Companies House · gsk.com/en-gb/media/press-releases/gsk-and-the-u | one source |